CN1434702A - 新的帕伐他丁钠形式 - Google Patents

新的帕伐他丁钠形式 Download PDF

Info

Publication number
CN1434702A
CN1434702A CN00818961A CN00818961A CN1434702A CN 1434702 A CN1434702 A CN 1434702A CN 00818961 A CN00818961 A CN 00818961A CN 00818961 A CN00818961 A CN 00818961A CN 1434702 A CN1434702 A CN 1434702A
Authority
CN
China
Prior art keywords
pravastatin sodium
pravastatin
solution
solvent
aprotic solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN00818961A
Other languages
English (en)
Chinese (zh)
Inventor
V·克里
C·绍博
E·N·阿维
J·阿伦希梅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceutical Works PLC
Original Assignee
Biogal Gyogyszergyar Rt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26866349&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN1434702(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biogal Gyogyszergyar Rt filed Critical Biogal Gyogyszergyar Rt
Publication of CN1434702A publication Critical patent/CN1434702A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
    • C07C69/33—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with hydroxy compounds having more than three hydroxy groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C07C67/52—Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/26—All rings being cycloaliphatic the ring system containing ten carbon atoms
    • C07C2602/28—Hydrogenated naphthalenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN00818961A 1999-12-14 2000-12-14 新的帕伐他丁钠形式 Pending CN1434702A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US17068599P 1999-12-14 1999-12-14
US60/170,685 1999-12-14
US19064900P 2000-03-20 2000-03-20
US60/190,649 2000-03-20

Publications (1)

Publication Number Publication Date
CN1434702A true CN1434702A (zh) 2003-08-06

Family

ID=26866349

Family Applications (1)

Application Number Title Priority Date Filing Date
CN00818961A Pending CN1434702A (zh) 1999-12-14 2000-12-14 新的帕伐他丁钠形式

Country Status (15)

Country Link
US (3) US7001919B2 (https=)
EP (1) EP1242051A4 (https=)
JP (2) JP2003516959A (https=)
KR (1) KR20020062340A (https=)
CN (1) CN1434702A (https=)
AU (1) AU779306B2 (https=)
CA (1) CA2394200C (https=)
CZ (1) CZ20021998A3 (https=)
HK (1) HK1049441A1 (https=)
HU (1) HUP0204005A3 (https=)
IL (1) IL150187A0 (https=)
PL (1) PL364929A1 (https=)
SK (1) SK8312002A3 (https=)
WO (1) WO2001043723A1 (https=)
YU (1) YU45202A (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1903825B (zh) * 2005-07-25 2010-09-15 丘比株式会社 普伐他汀钠的制造方法
CN101648867B (zh) * 2009-09-04 2012-07-11 天津大学 一种普伐他汀钠晶型及其制备方法和应用
CN111018714A (zh) * 2019-12-27 2020-04-17 广东蓝宝制药有限公司 一种获得高纯a晶型普伐他汀钠的制备方法

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL150187A0 (en) * 1999-12-14 2002-12-01 Biogal Pharmaceutical Co Ltd Novel forms of pravastatin sodium
WO2002092094A1 (en) * 2001-03-27 2002-11-21 Sumitomo Pharmaceuticals Co., Ltd. Crystalline isoxazole derivative and medical preparation thereof
WO2005084669A1 (en) * 2004-03-01 2005-09-15 Lek Pharmaceuticals D.D. Pharmaceutical composition
JP2008509154A (ja) 2004-08-06 2008-03-27 トランスフオーム・フアーマシユーチカルズ・インコーポレーテツド 新規なスタチン薬剤組成物および関連治療方法
CN101115706A (zh) * 2005-02-09 2008-01-30 特瓦药厂私人有限公司 制备普伐他汀钠的方法
EP2343054A1 (en) 2010-01-04 2011-07-13 LEK Pharmaceuticals d.d. Pellets and microparticles of pravastatin sodium and a process of making them
WO2012085191A1 (en) 2010-12-23 2012-06-28 Dsm Sinochem Pharmaceuticals Netherlands B.V. Crystalline form of pravastatine and process for the preparation thereof
MY180626A (en) 2013-11-15 2020-12-03 Akebia Therapeutics Inc Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
CN105949062B (zh) * 2016-06-24 2017-06-13 广东蓝宝制药有限公司 一种规模化制备普伐他汀钠d型晶体的工艺

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4319039A (en) * 1979-06-15 1982-03-09 Merck & Co., Inc. Preparation of ammonium salt of hypocholesteremic fermentation product
DK149080C (da) 1980-06-06 1986-07-28 Sankyo Co Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre
ATE69602T1 (de) 1985-09-13 1991-12-15 Sankyo Co Hydroxy-ml-236b-derivate, deren herstellung und anwendung.
US4857547A (en) * 1988-01-07 1989-08-15 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
US4857522A (en) 1988-03-21 1989-08-15 E. R. Squibb & Sons, Inc. Derivatives of pravastatin for inhibiting cholesterol biosynthesis
US5180589A (en) 1988-03-31 1993-01-19 E. R. Squibb & Sons, Inc. Pravastatin pharmaceuatical compositions having good stability
US5099035A (en) * 1989-02-27 1992-03-24 E. R. Squibb & Sons, Inc. Mevinic acid derivatives useful as antihypercholesterolemic agents and method for preparing same
US5140012A (en) 1990-05-31 1992-08-18 E. R. Squibb & Sons, Inc. Method for preventing onset of restenosis after angioplasty employing pravastatin
US5202029A (en) 1991-03-13 1993-04-13 Caron Kabushiki Kaisha Process for purification of hmg-coa reductase inhibitors
US5157025A (en) * 1991-04-01 1992-10-20 E. R. Squibb & Sons, Inc. Method for lowering serum cholesterol employing a phosphorus containing ace inhibitor alone or in combination with a cholesterol lowering drug
US5225202A (en) * 1991-09-30 1993-07-06 E. R. Squibb & Sons, Inc. Enteric coated pharmaceutical compositions
NZ250609A (en) 1992-12-28 1995-07-26 Sankyo Co Hexahydronaphthalene esters and ring closed lactones; preparation and medicaments
SI9300303A (en) * 1993-06-08 1994-12-31 Krka Tovarna Zdravil Process for isolation of hypolipemic effective substance
IL112639A0 (en) 1994-03-11 1995-05-26 Bristol Myers Squibb Co A pharmaceutical composition containing pravastin
US5942423A (en) * 1995-06-07 1999-08-24 Massachusetts Institute Of Technology Conversion of compactin to pravastatin by actinomadura
US5616595A (en) * 1995-06-07 1997-04-01 Abbott Laboratories Process for recovering water insoluble compounds from a fermentation broth
US5883109A (en) * 1996-07-24 1999-03-16 Bristol-Myers Squibb Company Method for lowering serum lipid levels employing an MTP inhibitor in combination with another cholesterol lowering drug
EP0975789A1 (en) 1997-02-20 2000-02-02 Dsm N.V. Nitrogen feed in statin fermentation
KR100210482B1 (ko) 1997-04-10 1999-07-15 김종인 스트렙토마이세스엑스포리아투스(streptomycesexfoliatus)yj-118과이를이용한프라바스타틴나트륨의제조방법
AU9264598A (en) 1997-08-22 1999-03-16 Gist-Brocades B.V. Statin production by fermentation
SI9800046A (sl) 1998-02-18 1999-08-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze visoke čistosti
SI20305A (sl) * 1999-08-06 2001-02-28 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Kristali natrijeve soli pravastatina
SI20072A (sl) 1998-09-18 2000-04-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze
WO2000033821A1 (en) * 1998-12-07 2000-06-15 Bristol-Myers Squibb Company Enteric coated pravastatin bead formulation
US6682913B1 (en) * 1999-02-03 2004-01-27 Institute For Drug Research Ltd. Microbial process for preparing pravastatin
CN1260344C (zh) 1999-02-03 2006-06-21 药物研究所有限公司 培养物
HUP9902352A1 (hu) 1999-07-12 2000-09-28 Gyógyszerkutató Intézet Kft. Eljárás pravasztatin mikrobiológiai előállítására
YU39102A (sh) * 1999-11-30 2006-01-16 Biogal Gyogyszergyar Rt Postupak dobijanja statina iz fermentacione smeše
IL150187A0 (en) * 1999-12-14 2002-12-01 Biogal Pharmaceutical Co Ltd Novel forms of pravastatin sodium
CN1468098A (zh) 2000-10-05 2004-01-14 �ݰ¸Ƕ�ҩ�����޹�˾ 基本上无普伐他汀内酯和表普伐他汀的普伐他汀钠和包含普伐他汀钠的组合物
DE10209305A1 (de) 2001-04-30 2002-10-31 Basf Ag Thermische Spaltung von Allophanaten

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1903825B (zh) * 2005-07-25 2010-09-15 丘比株式会社 普伐他汀钠的制造方法
CN101648867B (zh) * 2009-09-04 2012-07-11 天津大学 一种普伐他汀钠晶型及其制备方法和应用
CN111018714A (zh) * 2019-12-27 2020-04-17 广东蓝宝制药有限公司 一种获得高纯a晶型普伐他汀钠的制备方法

Also Published As

Publication number Publication date
US20010041809A1 (en) 2001-11-15
WO2001043723A1 (en) 2001-06-21
CA2394200A1 (en) 2001-06-21
PL364929A1 (en) 2004-12-27
KR20020062340A (ko) 2002-07-25
EP1242051A4 (en) 2004-05-12
YU45202A (sh) 2005-11-28
US20050288370A1 (en) 2005-12-29
HUP0204005A3 (en) 2003-05-28
AU2098701A (en) 2001-06-25
SK8312002A3 (en) 2003-05-02
HUP0204005A2 (hu) 2003-03-28
US7262218B2 (en) 2007-08-28
EP1242051A1 (en) 2002-09-25
AU779306B2 (en) 2005-01-13
CZ20021998A3 (cs) 2003-02-12
HK1049441A1 (zh) 2003-05-16
JP2005120105A (ja) 2005-05-12
US7001919B2 (en) 2006-02-21
US20070197633A1 (en) 2007-08-23
IL150187A0 (en) 2002-12-01
JP2003516959A (ja) 2003-05-20
CA2394200C (en) 2006-10-03

Similar Documents

Publication Publication Date Title
CN101679218B (zh) 晶体米诺环素碱及其制备方法
KR102522895B1 (ko) Jak 키나아제 억제제 바이설페이트의 결정형 및 이의 제조방법
CN1105705C (zh) 一种特定物理形态的杂环酰胺衍生物的制备方法
CN1161351C (zh) 新型s-奥美拉唑
US20070197633A1 (en) Novel forms of pravastatin sodium
JP2009149654A (ja) 多形性化合物
CN104797566A (zh) 沃替西汀氢溴酸盐的新结晶形式
CN1055693C (zh) 生物可利用的结晶形式头孢呋辛酯
KR20080089659A (ko) 아프레피탄트의 비정질 및 결정 형태 및 그것의 제조 방법
CN1747934A (zh) 匹伐他汀钙的晶形
CN1434708A (zh) 新的盐酸舍曲林多晶型物、其制备方法、含有它们的组合物和应用它们的方法
CN1898211A (zh) 喹啉化合物的晶形及其生产方法
CN1321149A (zh) 托拉沙得新晶体变型ⅲ
JP2002308895A (ja) ピリミジンヌクレオシド誘導体の結晶
WO2023034364A1 (en) Solid state forms of vericiguat and process for preparation thereof
TWI724651B (zh) 貝前列素-314d單水合物晶體及其製備方法
CN1395555A (zh) 二羧酸醚钙、其制备方法、和用其治疗血管疾病和糖尿病的方法
CN1617872A (zh) 三环型三唑并苯并氮杂䓬衍生物的非晶态物质
JP2023506025A (ja) レンボレキサントの固体形態
CN105985409A (zh) 一种卡非佐米马来酸盐结晶及其制备方法
CN1835935A (zh) Bifeprunox甲磺酸盐的稳定的多晶型物
CN1880294A (zh) 右酮洛芬氨丁三醇的多晶型、其制备方法和包含它的组合物
EP1523978A2 (en) Crystalline forms of pravastatin sodium
CN101048416A (zh) 有机化合物
WO2025191534A1 (en) Solid state forms of zasocitinib and process for preparation thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication